Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid function in patients with chronic renal failure.

V S Lim1

  • 1Nephrology Division, Department of Internal Medicine, University of Iowa Hospitals, Iowa City, IA, USA. victoria-lim@uiowa.edu

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|September 29, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein metabolism in chronic renal failure.

The International journal of artificial organs·2004
Same author

Protein intake in patients with renal failure: comments on the current NKF-DOQI guidelines for nutrition in chronic renal failure.

Seminars in dialysis·2001
Same author

Protein metabolism in patients with chronic renal failure: role of uremia and dialysis.

Kidney international·2000
Same author

The effect of uraemia, acidosis, and dialysis treatment on protein metabolism: a longitudinal leucine kinetic study.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1998
Same author

Leucine turnover in patients with nephrotic syndrome: evidence suggesting body protein conservation.

Journal of the American Society of Nephrology : JASN·1998
Same author

Dialysate sodium delivery can alter chronic blood pressure management.

American journal of kidney diseases : the official journal of the National Kidney Foundation·1997
Same journal

Hemophagocytic Lymphohistiocytosis and Fibroblast Growth Factor 23 (FGF23)-Induced Hypophosphatemia.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Kidney Transplantation Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Multiple Myeloma.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Palliative Dialysis: Putting the Person First in Dialysis Care.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Associations of Pre-Pandemic CKD With Acute and Post-Acute COVID-19: The C4R Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Metabolic Acidosis and Progression of CKD: Current Guidelines and Considerations.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Pathophysiology of Ketoacidosis: Core Curriculum 2026.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
See all related articles

Chronic renal failure lowers thyroid hormones (T3 and T4) due to impaired conversion and binding, not increased breakdown. This low thyroid state may protect against protein loss in kidney disease.

Area of Science:

  • Nephrology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Chronic renal failure (CRF) significantly impacts thyroid hormone homeostasis.
  • Patients exhibit reduced circulating triiodothyronine (T3) and thyroxine (T4) levels.
  • Altered hormone metabolism, binding, and increased iodine stores are characteristic of CRF.

Purpose of the Study:

  • To investigate the mechanisms behind altered thyroid function in chronic renal failure.
  • To determine the impact of CRF on thyroid hormone levels and metabolism.
  • To explore the potential protective role of the low thyroid state in CRF.

Main Methods:

  • Analysis of plasma thyroid hormone concentrations (T3, T4).
  • Assessment of peripheral hormone metabolism and binding to carrier proteins.

Related Experiment Videos

  • Evaluation of thyroid-stimulating hormone (TSH) response.
  • Examination of iodine content in thyroid glands.
  • Clinical trials administering LT3 to CRF patients.

    • Main Results:

    • Reduced plasma T3 and T4 levels observed in CRF patients.
    • Impaired extrathyroidal T4 to T3 conversion identified as the cause of low T3.
    • Circulating inhibitors affecting T4 binding to thyroxine-binding globulin contribute to reduced T4.
    • TSH levels are not elevated despite low thyroid hormones, indicating preserved hypothalamo-pituitary function.
    • Increased serum inorganic iodide and thyroidal iodine content, with frequent thyroid gland enlargement.
    • LT3 administration worsened nitrogen balance and increased protein degradation.

    Conclusions:

    • The low thyroid state in uremia is a complex adaptation, not simply hypothyroidism.
    • Impaired T4 to T3 conversion and altered T4 binding are key mechanisms in CRF.
    • The low thyroid state may serve a protective role against protein wasting in renal failure.
    • Therapeutic attempts to normalize thyroid hormone levels in CRF may exacerbate protein malnutrition.